Company / CapEx per Share
Vertex Pharmaceuticals CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$1.70
FY2025
5-year range
$0.78 / $1.70
FY2021-FY2025
Trend
+47.4%
vs FY2024
Sector context
#8 of 192
Health Care
What the data says
Among 192 Health Care companies, Vertex Pharmaceuticals is in the top 4% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $0.23 in FY2016 to $1.70 in FY2025.
Based on SEC 10-K filings.
1.70 in FY2025 with a 5-year CAGR of +11.2%. Top quartile in the Health Care sector.
Improved from $0.78 to $1.70 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +28.4%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 192This company $1.70 Sector average $3.54
▼
-51.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 47.4% year-over-year.
- Ranks #8 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | +47.4% |
| FY2024 | $1.16 | +48.2% |
| FY2023 | $0.78 | -3.1% |
| FY2022 | $0.80 | -11.0% |
| FY2021 | $0.90 | -9.9% |
| FY2020 | $1.00 | +239.5% |
| FY2019 | $0.30 | -21.6% |
| FY2018 | $0.38 | -5.9% |
| FY2017 | $0.40 | +74.4% |
| FY2016 | $0.23 | +22.6% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026